Onset Time of Brachial Plexus Block Using Local Anaesthetic Diluted With 0.9% Saline vs 5% Dextrose

NCT ID: NCT01815944

Last Updated: 2013-03-21

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 55 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2011-12-31
• Study Completion Date: 2012-10-31

Brief Summary

Regional anesthesia employs the use of local anesthetics (LA) to block specific nerves to enable pain free surgery to be performed, or for intra and post operative pain relief. Dilution of local anesthetics with normal saline (NS) is a common practice to enable larger volumes of LA to be given, for example, in instances where multiple nerve blocks are needed to be performed for optimal pain relief while avoiding toxic doses.

A high sodium concentration is known to antagonize the analgesic effect of local anesthetics. 5% dextrose (D5W) on the other hand is painless on injection and does not cause any long-term effects in animals or humans when injected around neurological tissue. In the literature, only one study using dextrose 5% as diluent to produce 0.5% ropivacaine for axillary brachial plexus block showed a statistically significant reduction in the onset time for sensory blockade when compared with dilution with NS.

In this study, 0.5% ropivacaine diluted with D5W or NS is used for ultrasound guided supraclavicular brachial plexus block, and the time for complete sensory and motor blockade was compared. 0.5% ropivacaine is easily diluted and is a common concentration used at our centre for nerve blocks. The aim of this study is to assess if 0.5% ropivacaine diluted with D5W results in a shorter onset time for sensory block which may change the current practice of dilution with NS

Detailed Description

• Patients randomly assigned to receive either 0.5% ropivacaine diluted with NS or D5W.
• Randomization followed a computer-generated randomization table and patients are blinded as to their group allocation.
• Group allocations are concealed in a sealed opaque envelope and only known to an independent anaesthesia trainee who prepares 20mls 0.5% ropivacaine
• The anaesthesiologist involved in the performance of the supraclavicular brachial plexus block is blinded to group allocation
• All ultrasound-guided supraclavicular blocks are performed by 2 anaesthesiologists who are familiar with the technique.
• A trained anaesthesiology trainee who is blinded to group allocation evaluated sensory loss and motor blockade every 5 mins after injection of local anaesthetic.
• The extent of sensory loss is tested in the median, radial, ulnar, and musculocutaneous nerve distributions and evaluated using a 3-point score: 2 = normal sensation, 1 =loss of sensation to pinprick (ie, analgesia), or 0 = loss of sensation to light touch (ie, anesthesia). The extent of motor blockade is tested in the distribution of the radial (thumb abduction), ulnar (thumb adduction), musculocutaneous (flexion of the elbow in supination and pronation), and median nerves (thumb opposition) and evaluated using a 3-point scale where 2 = normal movement, 1 = paresis, and 0 = absent movement.
• Block success is defined as loss of sensation to pinprick (sensory score 1) in each of the radial, ulnar, median, and musculocutaneous nerve distributions measured 60 mins after the end of local anaesthetic injection. Patients in whom block success was not achieved after 60 mins were excluded from data analysis.
• During the postoperative recovery period, pain (verbal response score 4 or patient request for analgesic) is treated with IV tramadol 25-50 mg slow bolus with or without fentanyl 25mcg boluses every 5 minutes as needed.
• When oral intake is allowed, patients will receive oral paracetamol 1g with oral diclofenac 50 mg or celecoxib 200mg, if not contraindicated.
• The block duration is subsequently taken as time from complete analgesia to the time when the patient first feels the slightest pain from the operative site.
• Patients are followed up twice; once on post-operative day (POD) 1 and once between POD 7-10.
• They are seen in the ward or are contacted via telephone and asked for the presence of any pain, weakness, numbness, tingling, or any abnormal sensation in the operative extremity.
• If indicated, they are then told to come to hospital for further evaluation and management as necessary.

Conditions

Comparison of Onset Time

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: QUADRUPLE

Study Groups

0.75% Ropivacaine and normal saline

Ultrasound-guided supraclavicular block using 0.75% ropivacaine diluted with normal saline

Group Type: ACTIVE_COMPARATOR

0.75% Ropivacaine

Intervention Type: DRUG

Normal saline

Intervention Type: DRUG

0.75% ropivacaine and dextrose 5%

Ultrasound guided supraclavicular block using 0.75% ropivacaine diluted with dextrose 5%

Group Type: EXPERIMENTAL

0.75% Ropivacaine

Intervention Type: DRUG

Dextrose 5%

Intervention Type: DRUG

Interventions

0.75% Ropivacaine

Intervention Type: DRUG

Normal saline

Intervention Type: DRUG

Dextrose 5%

Intervention Type: DRUG

Other Intervention Names

Naropin

Eligibility Criteria

Inclusion Criteria

• ASA I to III
• elective or emergency surgery of the hand, forearm and elbow

Exclusion Criteria

• diabetes mellitus
• neurological deficit
• contraindications to supraclavicular brachial plexus blockade
• unable to give consent
• patient refusal

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Malaya

OTHER

Sponsor Role: lead

Responsible Party

Dr Mohd Shahnaz

Dr

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

M. Shahnaz Hasan, MBBS, M Anes

Role: PRINCIPAL_INVESTIGATOR

University of Malaya

Locations

University Malaya Medical Centre

Kuala Lumpur, Kuala Lumpur, Malaysia

Countries

Malaysia

Other Identifiers

UMMC883.11

Identifier Type: -

Identifier Source: org_study_id